Carr Douglas 4
4 · Century Therapeutics, Inc. · Filed Mar 16, 2026
Research Summary
AI-generated summary of this filing
Century Therapeutics (IPSC) SVP Finance Carr Douglas Sells 7,043 Shares
What Happened
Carr Douglas, Senior Vice President of Finance & Operations at Century Therapeutics (IPSC), sold 7,043 shares on 2026-03-12 at $2.55 per share for a total of $17,953. The transaction is reported as a sale and was done to satisfy tax withholding obligations tied to vested restricted stock units (RSUs), per the filing footnote.
Key Details
- Transaction date: 2026-03-12; Price: $2.55 per share; Total proceeds: $17,953.
- Transaction type: Sale (reported as open market or private sale).
- Shares owned after the transaction: not disclosed in the provided filing.
- Footnote: The sale was automatic to cover tax withholding on RSU vesting and was not at the reporting person’s discretion.
- Filing: Form 4 filed 2026-03-16 for the 2026-03-12 transaction — appears timely (within the SEC’s two business-day window).
Context
This was a routine, tax-withholding sale related to RSU vesting (common for executives when shares vest). Such automatic withholding sales are typically administrative and don’t necessarily signal a change in the insider’s view of the company. The dollar value here is modest relative to typical insider trading headlines.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-12$2.55/sh−7,043$17,953→ 507,261 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.